Litcius/Paper detail

Medicinal Prospects of Targeting Tyrosinase: A Feature Review

Yuanyuan Wang, Baichen Xiong, Shuaishuai Xing, Ying Chen, Qinghong Liao, Jun Mo, Yao Chen, Qi Li, Haopeng Sun

2022Current Medicinal Chemistry26 citationsDOI

Abstract

Tyrosinase is a bifunctional polyphenol oxidase (PPO), catalyzing two oxidative reactions: monophenols to o-quinones (monophenolase activity) and o-diphenols to oquinones (diphenolase activity). As tyrosinase is the rate-limiting enzyme for the melanogenesis process, it is an attractive target for melanogenesis inhibition. Aiming at skin whitening, anticancer, Parkinson's disease (PD) treatment, antibacterial, fruit and vegetable preservation and other anti-pigmentation effect, medicinal chemists have exploited diverse tyrosinase inhibitors through various approaches. In addition to discovering inhibitors with novel scaffolds, good activity and high safety, researchers also focused on developing strategies for synergistic effects of multiple inhibitors and simultaneously regulating multiple targets to treat cancer or neurodegenerative diseases. This review focused on multiple natural and synthetic tyrosinase inhibitors, which could contribute to preventing fruit and vegetable browning, skin whitening, antibacterial, anticancer, Parkinson's Disease, etc.

Topics & Concepts

TyrosinaseChemistrySkin whiteningPolyphenolBrowningBiochemistryPharmacologyEnzymeAntioxidantMedicineActive ingredientmelanin and skin pigmentationBiochemical Analysis and Sensing TechniquesPhytochemicals and Antioxidant Activities
Medicinal Prospects of Targeting Tyrosinase: A Feature Review | Litcius